Drugs and drug development for chemotherapy of leprosy and tuberculosis, including M. avium infections
Seydel, J.K.
Tropical Medicine and Parasitology Official Organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft für Technische Zusammenarbeit 41(3): 341-343
1990
ISSN/ISBN: 0177-2392 PMID: 2255857 Document Number: 349514
Document emailed within 1 workday
Related Documents
Kondo, E.; Kanai, K. 1977: Experimental studies on the effective regimens of antituberculous drugs in the treatment of tuberculosis. II. Long-term chemotherapy in mice by daily and intermittent administration with changing drug combination Kekkaku: 52(8): 373-376Tomioka, H.; Tada, A. 2010: Can we have adequate chemotherapy regimens for tuberculosis in the future? Current status and future prospects for development of new antituberculosis drugs Kekkaku: 85(2): 113-123
De Clercq, E. 1986: Towards a selective chemotherapy of virus infections. Development of bromovinyldeoxyuridine as a highly potent and selective antiherpetic drug Verhandelingen - Koninklijke Academie Voor Geneeskunde van Belgie 48(4): 261-290
Chuchottaworn, C.; Saipan, B.; Kittisup, C.; Cheewakul, K. 2012: Adverse drug reactions and outcome of short course anti-tuberculosis drugs between single daily dose and split drug dose (BID) in pulmonary tuberculosis Journal of the Medical Association of Thailand 95(Suppl 8): S1-S5
Kuze, F.; Sakurai, N.; Ogino, F.; Togawa, S. 1986: Combined versus single-drug studies on susceptibilities of Mycobacterium avium-intracellulare to antituberculosis drugs on Ogawa medium Kekkaku: 61(6): 341-349
Mehta, J.M. 1981: Note on medical certification in respect of leprosy patients vis-a-vis reservation in service for the physically handicapped including those due to leprosy Leprosy in India 53(1): 96-98
Emori, M.; Saito, H.; Tomioka, H.; Setogawa, T. 1994: Development of experimental model animals for disseminated Mycobacterium avium complex infections using immunodeficient mice and rats Kekkaku: 69(4): 317-322
Sunpath, H.; Edwin, C.; Chelin, N.; Nadesan, S.; Maharaj, R.; Moosa, Y.; Smeaton, L.; Court, R.; Knight, S.; Gwyther, E.; Murphy, R.A. 2012: Operationalizing early antiretroviral therapy in HIV-infected in-patients with opportunistic infections including tuberculosis International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 16(7): 917-923
Hermans, P.W.; Hartskeerl, R.A.; Thole, J.E.; Klatser, P.R. 1990: Development of diagnostic tests for leprosy and tuberculosis Tropical Medicine and Parasitology: Official Organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft für Technische Zusammenarbeit 41(3): 301-303
Foroumadi, A.; Soltani, F.; Moshafi, M.H. 2002: Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis Bollettino Chimico Farmaceutico 141(5): 394-396
Sasaki, Y.; Mochizuki, K.; Shigeto, E.; Konishiike, J. 1986: Present status and chemotherapy of extrapulmonary tuberculosis in national sanatoria--urinary tuberculosis. Report of the B series of 26th Controlled Trials of Chemotherapy--Cooperative Study Unit of Chemotherapy of Tuberculosis of National Sanatoria in Japan (CSUCTNS) Kekkaku: 61(1): 9-13
Tejasvi, T.; Khaitan, B.K.; Khanna, N.; Pandhi, R.K.; Singh, M.K. 2006: Evaluation of a new fixed duration (12 weeks) multi-drug regimen of bactericidal drugs in multibacillary leprosy Indian Journal of Leprosy 78(4): 329-337
Waters, M.F. 1986: Concepts behind the development of multiple drug therapy regimens in leprosy Ethiopian Medical Journal 24(Suppl 1): 61-67
Matthiessen, W.; Kind, A.; Göbel, D. 1977: Epidemiology of primary drug resistance in tuberculosis in the Federal Republic of Germany including Berlin (West) during 1972 to 1975 Praxis und Klinik der Pneumologie 31(10): 890-898
Vladimirskiĭ, M.A.; Strel'tsov, V.P.; Stapanov, V.M.; Braude, V.I. 1980: Liposomes as vehicles of antitubercular drugs - a new appraoch to experimental chemotherapy of tuberculosis Problemy Tuberkuleza 7: 53-56
Hladůvková, J.; Waisser, K.; Kaustová, J. 2001: Development of chemotherapy in tuberculosis Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti 50(1): 4-11
Foroumadi, A.; Soltani, F. 2003: Antituberculosis agents. IX. in vitro antimycobacterial activity of N-(2-phenyl-2-oxoethyl) and N-[2-(4-fluorophenyl)-2-oxoethyl]ciprofloxacin derivatives against some drug-resistant strains of Mycobacterium tuberculosis and Mycobacterium avium isolates Bollettino Chimico Farmaceutico 142(6): 248-250
Sulistijawati, R.Sri.; Icksan, A.Ghanie.; Lolong, D.Bisara.; Nurwidya, F. 2019: Thoracic Radiography Characteristics of Drug Sensitive Tuberculosis and Multi Drug Resistant Tuberculosis: A Study of Indonesian National Tuberculosis Prevalence Survey Acta Medica 62(1): 24-29
Tubura, E. 1991: Pulmonary tuberculosis in the compromised host--report of the 30th B series of controlled trials of chemotherapy--Cooperative Study Unit of Chemotherapy of Tuberculosis of the National Sanatoria in Japan Kekkaku: 66(2): 95-99
Adamovich, V.N.; Gur'ian, I.E.; Reĭderman, I.B.; Deev, A.D. 1974: The tuberculostatic test in patients with chronic destructive pulmonary tuberculosis during chemotherapy with ethambutol combined with drugs of the first and second series Antibiotiki 19(4): 371-374